KCM
CVS icon

KRS Capital Management’s CVS Health CVS Stock Holding History

KRS Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,530
Closed -$202K – 117
2024
Q1 		$202K Sell
2,530
-434
-15% -$33.2K 0.16% 116
2023
Q4 		$234K Sell
2,964
-40
-1% -$2.85K 0.22% 105
2023
Q3 		$210K Sell
3,004
-2,326
-44% -$165K 0.22% 110
2023
Q2 		$368K Sell
5,330
-1,674
-24% -$119K 0.37% 76
2023
Q1 		$520K Buy
7,004
+211
+3% +$17.7K 0.59% 49
2022
Q4 		$633K Buy
6,793
+165
+2% +$15.9K 0.87% 35
2022
Q3 		$632K Buy
6,628
+431
+7% +$42.7K 0.87% 30
2022
Q2 		$574K Sell
6,197
-127
-2% -$12.4K 0.82% 34
2022
Q1 		$640K Buy
6,324
+516
+9% +$54.2K 0.69% 44
2021
Q4 		$599K Buy
+5,808
New +$537K 0.51% 50

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

KRS Capital Management's CVS Position: Q2 2024 in Review

KRS Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,530 shares — an estimated $202K sold.

KRS Capital Management first reported a position in CVS in Q4 2021 and held it in 10 quarters. The position peaked at $640K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • KRS Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • KRS Capital Management sold 2,530 CVS Health shares in Q2 2024, an estimated $202K.
  • KRS Capital Management first reported a position in CVS Health in Q4 2021 and held it in 10 quarters.
  • KRS Capital Management's CVS Health position peaked at $640K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on KRS Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.